Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2B6 Activity and Efavirenz Interactions in Healthy Volunteers
NCT02401256Phase 4Completed
- Sponsor
- Indiana University
- Start
- Jul 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by Indiana University. Started Jul 2013; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02401256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401256.